Language : EN
Views：11
Recently, Specialty Probiotics Australia (SPA), H&S Global's TGA-certified probiotic manufacturing facility in Australia, successfully secured a long-term production contract with Biome Australia (ASX: BIO), a company listed on the Australian Securities Exchange (ASX). The agreement further demonstrates the Group's comprehensive capabilities in health and nutrition manufacturing, supply chain integration, and industrial synergy.
Biome Australia is one of Australia's leading microbiome health companies. Its Activated Probiotics? brand has broad market coverage across pharmacy, health food, and practitioner channels, and continues to expand internationally. In recent years, Biome has become an important brand in Australia's health and nutrition market through its professional focus on microbiome health and continued growth.
Under the cooperation plan, SPA will progressively undertake localized Australian production of the Activated Probiotics? range over approximately the next 18 months. Once implemented, the project will further enhance Australia's local probiotic manufacturing capability while improving supply chain efficiency and market responsiveness, providing more stable and reliable production support for the brand's long-term growth.
The project will not only help advance local production capabilities in Australia, but also reflects the high priority global health brands place on supply chain stability, product quality, and long-term sustainable development.
This cooperation reflects industry recognition of SPA's production capability, quality system, and professional technical strength. As a specialist probiotic manufacturing facility under H&S Global, Specialty Probiotics Australia (SPA) holds Australian TGA-certified manufacturing qualifications and focuses on R&D, production, and commercial manufacturing services for probiotics and microbiome health products.
With a rigorous quality management system, advanced production technology platform, and manufacturing processes aligned with international standards, SPA continues to provide high-quality, scalable professional manufacturing solutions for global health brands.
In recent years, H&S Global has continued to advance its global supply chain strategy by actively investing in and integrating high-quality upstream resources, strengthening capabilities in R&D, raw materials, production, and quality management. Through long-term strategic partnerships with leading global raw material suppliers, research institutions, and manufacturing partners, the Group continues to reinforce its layout and management of key raw materials, core technologies, and production processes, controlling product quality and manufacturing standards from the source while enhancing product quality, supply chain resilience, and market competitiveness.
Securing this long-term production contract with Biome Australia not only demonstrates market recognition of SPA's professional capability in probiotic manufacturing, but also further validates H&S Global's comprehensive strengths in quality management, production operations, and supply chain integration. As more international health brands choose to work with SPA, the Group's influence within Australia's health and nutrition industry chain continues to grow.
Looking ahead, H&S Global will continue to deepen its global supply chain layout, enhance R&D innovation, quality management, and manufacturing capabilities, and work with high-quality global partners to provide consumers worldwide with health and nutrition products that are higher quality, safer, and more trusted.
The cooperation described in this article is based on an announcement released by Biome Australia on the Australian Securities Exchange (ASX) on June 3, 2026.
